Mist1-null mice are resistant to streptozotocin-induced β cell damage

Biochemical and Biophysical Research Communications

Volumn 353, Issue 3, 2007, Pages 823-828

  Fazio, Elena N ^a   Pin, Christopher L ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Basic helix loop helix; Glut 2; Pancreatic islets; Transcription factor

Indexed keywords

STREPTOZOCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MIST1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GENE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; MIST1 GENE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLUCAGON; GLUCOSE TRANSPORTER TYPE 2; INSULIN; INSULIN-SECRETING CELLS; ISOPROPYL THIOGALACTOSIDE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; STREPTOZOCIN;

MUS;

EID: 33845995773     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.110     Document Type: Article

References (20)

1. Anderson T., Schein P.S., McMenamin M.G., and Cooney D.A. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide. J. Clin. Invest. 54 (1974) 672-677
2. Bedoya F.J., Solano F., and Lucas M. N-Monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets. Experientia 52 (1996) 344-347
3. Burcelin R., Eddouks M., Kande J., Assan R., and Girard J. Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats. Biochem. J. 288 Pt 2 (1992) 675-679
4. Dufrane D., van Steenberghe M., Guiot Y., Goebbels R.M., Saliez A., and Gianello P. Streptozotocin-induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and beta-cell plasticity. Transplantation 81 (2006) 36-45
5. Fazio E.N., Everest M., Colman R., Wang R., and Pin C.L. Altered Glut-2 accumulation and beta-cell function in mice lacking the exocrine-specific transcription factor, Mist1. J. Endocrinol. 187 (2005) 407-418
6. Guillam M.T., Hummler E., Schaerer E., Yeh J.I., Birnbaum M.J., Beermann F., Schmidt A., Deriaz N., Thorens B., and Wu J.Y. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat. Genet. 17 (1997) 327-330
7. Hosokawa M., Dolci W., and Thorens B. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. Biochem. Biophys. Res. Commun. 289 (2001) 1114-1117
8. Kroncke K.D., Fehsel K., Sommer A., Rodriguez M.L., and Kolb-Bachofen V. Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage. Biol. Chem. Hoppe Seyler 376 (1995) 179-185
9. Noonan W.T., Shapiro V.M., and Banks R.O. Renal glucose reabsorption during hypertonic glucose infusion in female streptozotocin-induced diabetic rats. Life Sci. 68 (2001) 2967-2977
10. Pin C.L., Bonvissuto A.C., and Konieczny S.F. Mist1 expression is a common link among serous exocrine cells exhibiting regulated exocytosis. Anat. Rec. 259 (2000) 157-167
11. Pin C.L., and Merrifield P.A. Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles. Dev. Biol. 188 (1997) 147-166
12. Pin C.L., Rukstalis J.M., Johnson C., and Konieczny S.F. The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity. J. Cell Biol. 155 (2001) 519-530
13. Rerup C.C. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22 (1970) 485-518
14. Thorens B. Molecular and cellular physiology of GLUT-2, a high-Km facilitated diffusion glucose transporter. Int. Rev. Cytol. 137 (1992) 209-238
15. Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am. J. Physiol. 270 (1996) G541-G553
16. Thorens B., Guillam M.T., Beermann F., Burcelin R., and Jaquet M. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J. Biol. Chem. 275 (2000) 23751-23758
17. Thorens B., Sarkar H.K., Kaback H.R., and Lodish H.F. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell 55 (1988) 281-290
18. Turk J., Corbett J.A., Ramanadham S., Bohrer A., and McDaniel M.L. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 197 (1993) 1458-1464
19. Wang Z., and Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 47 (1998) 50-56
20. Weiss R.B. Streptozocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat Rep. 66 (1982) 427-438